# Filing Detail

Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-18-175433
Filing Date
2018-05-25
Accepted
2018-05-25 16:48:09
Documents
7

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B4 | d522368d424b4.htm | 424B4 | 1963853
2 | GRAPHIC | g522368g19c10.jpg | GRAPHIC | 130605
3 | GRAPHIC | g522368g20i14.jpg | GRAPHIC | 131580
4 | GRAPHIC | g522368g29x80.jpg | GRAPHIC | 136035
5 | GRAPHIC | g522368g43z47.jpg | GRAPHIC | 83256
6 | GRAPHIC | g522368g47p15.jpg | GRAPHIC | 159013
7 | GRAPHIC | g522368g73n73.jpg | GRAPHIC | 47677
| Complete submission text file | 0001193125-18-175433.txt |  | 2913609

Mailing Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2
Business Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-224582 | Film No.: 18862174
SIC: 2834 Pharmaceutical Preparations